Stock Track | Tilray Inc. Plummets 7.21% Intraday as Investors Sell on Trump's Marijuana Reclassification News

Stock Track12-19 22:40

Tilray Inc. (TLRY) saw its shares drop sharply by 7.21% during intraday trading on Friday, despite pre-market gains following President Trump's executive order reclassifying marijuana as a Schedule III drug.

The decline reflects a "sell-the-news" reaction, as investors had anticipated more significant policy changes, such as recreational legalization or broader commercial benefits. While the reclassification eases restrictions on medical marijuana research, it does not legalize recreational use, leading to profit-taking after initial optimism. Tilray's announcement of Tilray Medical USA, focused on medical-grade products, failed to offset the disappointment over limited immediate commercial impacts.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192853038?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-19 22:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192853038","market":"nz","top_or_hot":-1,"title":"Stock Track | Tilray Inc. Plummets 7.21% Intraday as Investors Sell on Trump's Marijuana Reclassification News","media":"Stock Track","content":"<p>Tilray Inc. (TLRY) saw its shares drop sharply by 7.21% during intraday trading on Friday, despite pre-market gains following President Trump's executive order reclassifying marijuana as a Schedule III drug.</p><p>The decline reflects a \"sell-the-news\" reaction, as investors had anticipated more significant policy changes, such as recreational legalization or broader commercial benefits. While the reclassification eases restrictions on medical marijuana research, it does not legalize recreational use, leading to profit-taking after initial optimism. Tilray's announcement of Tilray Medical USA, focused on medical-grade products, failed to offset the disappointment over limited immediate commercial impacts.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tilray Inc. Plummets 7.21% Intraday as Investors Sell on Trump's Marijuana Reclassification News</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tilray Inc. Plummets 7.21% Intraday as Investors Sell on Trump's Marijuana Reclassification News\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-12-19 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tilray Inc. (TLRY) saw its shares drop sharply by 7.21% during intraday trading on Friday, despite pre-market gains following President Trump's executive order reclassifying marijuana as a Schedule III drug.</p><p>The decline reflects a \"sell-the-news\" reaction, as investors had anticipated more significant policy changes, such as recreational legalization or broader commercial benefits. While the reclassification eases restrictions on medical marijuana research, it does not legalize recreational use, leading to profit-taking after initial optimism. Tilray's announcement of Tilray Medical USA, focused on medical-grade products, failed to offset the disappointment over limited immediate commercial impacts.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TLRY","symbol_name":"Tilray Inc.","start_time":0,"source_url":"","article_id":"1192853038","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192853038","pubTimestamp":1766155237,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tilray Inc. (TLRY) saw its shares drop sharply by 7.21% during intraday trading on Friday, despite pre-market gains following President Trump's executive order reclassifying marijuana as a Schedule...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TLRY":"Tilray Inc."},"translate_title":"个股追踪|Tilray Inc.盘中暴跌7.21%投资者因特朗普大麻重新分类消息抛售","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TLRY":1},"content_text":"Tilray Inc. (TLRY) saw its shares drop sharply by 7.21% during intraday trading on Friday, despite pre-market gains following President Trump's executive order reclassifying marijuana as a Schedule III drug.The decline reflects a \"sell-the-news\" reaction, as investors had anticipated more significant policy changes, such as recreational legalization or broader commercial benefits. While the reclassification eases restrictions on medical marijuana research, it does not legalize recreational use, leading to profit-taking after initial optimism. Tilray's announcement of Tilray Medical USA, focused on medical-grade products, failed to offset the disappointment over limited immediate commercial impacts.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192853038","isCrawlerRequest":true}